TCMDTactile Systems Technology, Inc.

$22.11+49% 1Y

$22.11

$14.2252 weeks$33.05

Is the price fair?

Good

Undemanding: modest expectations priced in and cheap against its own history.

2 good, 1 without data

What the price assumes~+5% a yearderived · Jun 30, 2026

Priced for ~5% a year FCF growth. The price demands less than its three-year revenue growth of 10% a year, expectations look modest.

Vs its own P/E range75% below its own medianderived

Cheap vs its own history: P/E 20.5 vs a 81.5 median over 27 quarters (−75% vs median).

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

Tactile Systems Technology, Inc. trades at 20.5× earnings against 25.8× for the median Medical Devices name, cheaper than its own group.

20.5

Trailing P/E · Medical Devices median 25.8 · cheaper than the typical name in its group

Price / sales: 1.72
Price / sales · as of 2026-Q1
Free cash flow yield: 5.4%
Free cash flow yield · Medical Devices median 4.5%
Growth the price implies: +4.7%
Growth the price implies · The price pays for +4.7% free cash flow growth a year for a decade; the business has delivered +16% a year over the last three.